Home / Inspections / 1137467

FDA Inspection 1137467 — Frontida Biopharm, LLC

Frontida Biopharm, LLC — FEI 3008087151

The FDA completed an inspection of Frontida Biopharm, LLC on February 26, 2021 in Aurora, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 26, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Aurora, IL (United States)

Facility

Other inspections at this facility

  • 1283762 (VAI Fri Oct 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 961359 (NAI Thu Feb 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 820917 (NAI Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 739828 (NAI Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 637304 (NAI Tue Jan 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources